GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (FRA:8NN) » Definitions » 3-Year FCF Growth Rate

Thor Medical ASA (FRA:8NN) 3-Year FCF Growth Rate : 70.90% (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA 3-Year FCF Growth Rate?

Thor Medical ASA's Free Cash Flow per Share for the six months ended in Dec. 2024 was €-0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 70.90% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 56.80% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 20.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Thor Medical ASA was 70.90% per year. The lowest was -99.20% per year. And the median was -10.20% per year.


Competitive Comparison of Thor Medical ASA's 3-Year FCF Growth Rate

For the Biotechnology subindustry, Thor Medical ASA's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thor Medical ASA's 3-Year FCF Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Thor Medical ASA's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Thor Medical ASA's 3-Year FCF Growth Rate falls into.


;
;

Thor Medical ASA 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Thor Medical ASA  (FRA:8NN) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Thor Medical ASA 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Thor Medical ASA's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Thor Medical ASA Business Description

Traded in Other Exchanges
Address
Karenslyst Alle 9C, Oslo, NOR, 0278
Thor Medical ASA is a company engaged in producing and supplying of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium (Th-232). The objective of the company is to supply alpha emitters to suppliers and developers of innovative drugs targeting indications of high unmet medical need, including any medical products and equipment, and to run business related thereto or associated therewith.

Thor Medical ASA Headlines

No Headlines